High preoperative serum alanine transferase levels: Effect on the risk of liver resection in child grade a cirrhotic patients

被引:51
作者
Noun, R [1 ]
Jagot, P [1 ]
Farges, O [1 ]
Sauvanet, A [1 ]
Belghiti, J [1 ]
机构
[1] UNIV PARIS 07,HOP BEAUJON,DEPT HEPATOBILIARY & DIGEST SURG,F-92118 CLICHY,FRANCE
关键词
D O I
10.1007/PL00012259
中图分类号
R61 [外科手术学];
学科分类号
摘要
Despite careful selection of cirrhotic patients with hepatocellular carcinoma (HCC), liver resection remains associated with a greater risk than in patients without underlying liver disease. In this study we assessed by multivariate analysis parameters associated with in-hospital mortality and morbidity in a selected group of 108 Childs-Pugh A cirrhotic patients undergoing liver resection of HCC. The overall incidences of in-hospital deaths and postoperative complications were 8.3% and 48.1%, respectively. By univariate analysis, the preoperative serum alanine transferase (ALT) level (p = 0.001) and intraoperative transfusions (p = 0.01) were significantly associated with in-hospital death; however, only the serum ALT concentration was an independent risk factor. In-hospital mortality rates in patients whose serum ALT was below 2N (twofold the upper limit of the normal value), between 2N and 4N, and more than 4N were 3.9%, 13.0%, and 37.5%, respectively. An ALT level greater than 2N was predominantly observed in patients with a hepatitis C virus infection and significantly associated with histologic features of superimposed active hepatitis. Patients with an ALT level greater than 2N experienced an increased incidence of postoperative ascites (58% versus 32%, p = 0.01), kidney failure (16% versus 0%, p = 0.0003), and upper gastrointestinal bleeding (6.4% versus 0%, p = 0.02). These results indicate that the preoperative ALT level is a reliable predictor of in-hospital mortality and morbidity following liver resection in Child-Pugh A cirrhotic patients. Cirrhotic patients with ALT > 2N should undergo only a limited resection; if a larger resection is required, those patients should be considered for nonsurgical therapy or liver transplantation.
引用
收藏
页码:390 / 395
页数:6
相关论文
共 34 条
[1]   RISK-FACTORS FOR INTRAHEPATIC RECURRENCE IN HUMAN SMALL HEPATOCELLULAR-CARCINOMA [J].
ADACHI, E ;
MAEDA, T ;
MATSUMATA, T ;
SHIRABE, K ;
KINUKAWA, N ;
SUGIMACHI, K ;
TSUNEYOSHI, M .
GASTROENTEROLOGY, 1995, 108 (03) :768-775
[2]  
BELGHITI J, 1991, BRIT J SURG, V78, P257, DOI 10.1002/bjs.1800780302
[3]   LIVER RESECTIONS IN CIRRHOTIC-PATIENTS - A WESTERN EXPERIENCE [J].
BISMUTH, H ;
HOUSSIN, D ;
ORNOWSKI, J ;
MERIGGI, F .
WORLD JOURNAL OF SURGERY, 1986, 10 (02) :311-317
[4]   RESULTS OF MAJOR HEPATECTOMY FOR LARGE PRIMARY LIVES CANCER IN PATIENTS WITH CIRRHOSIS [J].
CAPUSSOTTI, L ;
BORGONOVO, G ;
BOUZARI, H ;
SMADJA, C ;
GRANGE, D ;
FRANCO, D .
BRITISH JOURNAL OF SURGERY, 1994, 81 (03) :427-431
[5]   HEPATOCELLULAR-CARCINOMA IN ITALIAN PATIENTS WITH CIRRHOSIS [J].
COLOMBO, M ;
DEFRANCHIS, R ;
DELNINNO, E ;
SANGIOVANNI, A ;
DEFAZIO, C ;
TOMMASINI, M ;
DONATO, MF ;
PIVA, A ;
DICARLO, V ;
DIOGUARDI, N .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (10) :675-680
[6]   PERIOPERATIVE NUTRITIONAL SUPPORT IN PATIENTS UNDERGOING HEPATECTOMY FOR HEPATOCELLULAR-CARCINOMA [J].
FAN, ST ;
LO, CM ;
LAI, ECS ;
CHU, KM ;
LIU, CL ;
WONG, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (23) :1547-1552
[7]  
FAN ST, 1995, ARCH SURG-CHICAGO, V130, P198
[8]  
GOZZETTI G, 1988, SURG GYNECOL OBSTET, V166, P503
[9]   INFLUENCE OF VIRAL-HEPATITIS STATUS ON OPERATIVE MORBIDITY AND MORTALITY IN PATIENTS WITH PRIMARY HEPATOCELLULAR-CARCINOMA [J].
HIGASHI, H ;
MATSUMATA, T ;
ADACHI, E ;
TAKETOMI, A ;
KASHIWAGI, S ;
SUGIMACHI, K .
BRITISH JOURNAL OF SURGERY, 1994, 81 (09) :1342-1345
[10]   RESULTS OF HEPATIC RESECTION FOR HEPATOCELLULAR-CARCINOMA [J].
KAWASAKI, S ;
MAKUUCHI, M ;
MIYAGAWA, S ;
KAKAZU, T ;
HAYASHI, K ;
KASAI, H ;
MIWA, S ;
HUI, AM ;
NISHIMAKI, K .
WORLD JOURNAL OF SURGERY, 1995, 19 (01) :31-34